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In the original article, there was an error in the GEO database accession number. The correct GEO
database accession number for gene expression data of denatonium-treated cells is GSE149548.
A correction has been made to the “Methods” section, paragraph 2, and the Data
Availability Statement:GENE EXPRESSION PROFILING (GEP)
TAS2R expression was analyzed in 61 AML, 49 from a published dataset (32) and 12 new cases. As
validation set, we used also 183 AML samples downloaded from The Cancer Genome Atlas (TCGA)
(https://gdc.cancer.gov/about-data/publications/laml_2012)(33). GEP after DEN treatment was
performed in 5 newly diagnosed AML samples and THP-1 and OCI-AML3 cell lines. Three
independent replicates of each condition were hybridized to Human Clariom S Arrays (Thermo Fisher
Scientific) according to themanufacturer’s recommendations. Data quality control, normalization (signal
space transformation robust multiple-array average), and supervised analysis were carried out by
Expression Console and Transcriptome Analysis Console software, respectively (Thermo FisherApril 2021 | Volume 11 | Article 6684601
Salvestrini et al. Corrigendum: Bitter Taste Receptors in LeukemiaScientific). For AML cells, data were normalized on vehicle-treated
cells before comparison. Genes with a 1.5 fold difference and p≤ 0.05
were considered for enrichment analyses.Downstreamanalyseswere
performed as reported in (32,34), and with Thomson Reuter’s
MetaCore software suite (Clarivate Analytics, Philadelphia, PA,
USA). Gene expression data of denatonium-treated cells will be
publicly available on the GEO database under the accession
number GSE149548.
DATA AVAILABILITY STATEMENT
The datasets presented in this study can be found in online
repositories. The names of the repository/repositories andFrontiers in Oncology | www.frontiersin.org 2accession number(s) can be found below: the NCBI Gene
Expression Omnibus (GSE149548).
The authors apologize for these errors and state that this do
not change the scientific conclusions of the article in any way.
The original article has been updated.
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